The sterilisation and disinfectant market in Europe has been witnessing slow growth as hospitals try to tackle alarmingly high infection rates resulting from inadequately decontaminated patient care equipment. However, the market is mature and saturated, offering little scope for technological innovation, and the complete lack of product differentiation is hampering competition. While the disinfection market has shown potential for expansion, the sterilisation market remains largely static.
New analysis from Frost & Sullivan (http://www.medicaldevices.frost.com), European Sterilisation and Disinfection Equipment Market, finds that the market earned revenues of over USD269.7 million in 2007 and estimates this to reach USD352.0 million in 2014.
“Though the sterilisation and disinfection equipment market is not characterised by a strong level of technological development, certain mutations are contributing to the overall positive growth,” says Frost & Sullivan Research Analyst Kieu A. Vuong. “For instance, slack growth in the low-temperature gas steriliser segments is compensated by positive trends impacting the disinfector equipment sector.”
The spurt in the number of surgical procedures utilising minimally invasive instruments such as endoscopes is also driving the need for sophisticated systems for proper disinfection and maintenance of such equipment. This demand for more efficient disinfecting methods is fuelling the growth of the automatic endoscope reprocessor (AER) segment. The washers and AER disinfection markets are exhibiting continuous growth due to advancements in surgical instrumentation and liquid chemical disinfectants as well.
However, emerging trends indicate increasing consolidation and centralisation of hospitals in Europe, drastically reducing the number of hospitals and the number of potential customers. End-user consolidation is a challenge for this market, as purchasing power is augmented.
“High prices along with slow rate of product replacement will force manufacturers to identify different revenue streams in order to maintain and increase their profit margins,” notes Vuong. “Despite several attempts at creating a unified platform, insecurities concerning the standardisation and regulation of products continue.”
Nonetheless, participants can accrue revenues by providing integrated service packages and proper nurturing of customer relationships, since virtually all hospitals are already equipped with infection control equipment. To achieve the high standards required for service packages, many companies have entered into partnerships to reduce costs and enhance their offering.
If you are interested in a virtual brochure, which provides manufacturers, end users and other industry participants with an overview of the European sterilisation and disinfection equipment market, then send an e-mail to Patrick Cairns, Corporate Communications, at pcairns_pr@frost.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you by e-mail.
European Sterilisation and Disinfection Equipment Market is part of the Medical Devices Growth Partnership Service programme, which also includes research in the following markets: cardiovascular, wound care, surgical, orthopaedic and others. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.
Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership™ empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan’s Growth Partnerships, visit http://www.frost.com.
European Sterilisation and Disinfection Equipment Market
M236
Contacts:
Corporate Communications –
Europe & Africa
Patrick Cairns, +27 18 468 2315
patrick.cairns@frost.com
or
Corporate
Communications – North America
Stacie
Kopecki, 210-247-2450
fax: 210-348-1003
stacie.kopecki@frost.com
or
Corporate
Communications – Asia Pacific
Jasminder
Kaur, 65-6890-0937
fax: 65-6890-0988
jkaur@frost.com
or
Corporate
Communications – South Asia
Remi
Chatterjee, +91-44-4001 3419
fax: +91-22-2832 4713
remi.chaterjee@frost.com
or
Corporate
Communications – Middle East
Nimisha
Iyer, +91 22 4001 3404
fax: +91 22 2832 4713
niyer@frost.com
or
Corporate
Communications – China
Amelia Wong, +86
21 5407 5783, ext. 8669
cell: +86 13621724823
amelia.wong@frost.com
or
Corporate
Communications – Latin America
José
María Jantus, + 54-11-4777-9951
fax: +
54-11-4777-0071
jose.jantus@frost.com
http://www.frost.com
